Publications 1996

  1. A comparison of induction of labor with expectant management for prelabor rupture of membrances at term. New England Journal of Medicine. 334:1005-1010. 1996 M. Hannah, A. Ohlsson, D. Farine, S. Hewson, E. Hodnett, T. Myhr, E. Wang, J. Weston, A. Willan.
  2. A controlled trial of nurse practitioners in neonatal intensive care. Pediatrics. 98:1143-1147. 1996 A. Mitchell-DiCenso, G. Guyatt, M. Marrin, R. Goeree, A. Willan, D. Southwell, S. Hewson, B. Paes, P. Rosenbaum, M. Hunsberger, A. Baumann.
  3. A randomized trial to evaluate two information packages mailed to new patients prior to their initial appointment at a regional cancer centre. British Journal of Cancer. 73:1588-1593 1996 E.A. Mohide, T. Whelan, D. Rath, A. Gafni, A. Willan, D. Czukar, I. Campbell, G. Akawara, M. Neimanis, M. Levine.
  4. A radomized trial of low molecular weight heparin administered primarily at home comared with in-hospital unfractionated heparin in the treatment of patients with proximal deep vein thrombosis. New England Journal of Medicine. 334:677-681. 1996 M. Levine, M. Gent, J. Hirsh, A. Willan.
  5. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for under-treatment in women and the elderly, Archives of Internal Medicine 1996;156:799-805 McLaughlin TJ, Soumerai SB, Willison DJ, et.al.
  6. An assessment of the burden of illness due to osteoporosis in Canada. Journal of the Society of Obstetric and Gynecology of Canada, 1996;Supp:15-24. Goeree R, O'Brien B, Adachi J, Cuddy L, Pettitt D.
  7. Argon green vs krypton red laser photocoagulation of extrafoveal choroidal Neovascular Lesions: Three-year results in age-related macular generation. Canadian Journal of Ophthalmology. 31:11-17. 1996 A. Willan, A.F. Cruess, M. Ballantyne.
  8. Ardeparin (low-molecular-weight heparin) vs graduated compression strockings for the prevention of venous thromboembolism: a randomized trial in patients undergoing knee surgery. Archive of Internal Medicine. 156:851-856. 1996 M.N.Levine, M.Gent, J. Hirsh, J.Weitz, A.Turpie, P.Powers, J.Neemeh, A. Willan, P. Skingley.
  9. Clinical economics review: cost-effectiveness of treatment alternatives for gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics., 1996;10(6):865-873. Sridhar S, Huang J, O'Brien BJ, Hunt R.
  10. Clinical Pharmacology. Paradise Lost? Can.J.Clin.Pharmacol.3:120-121, 1996 MacLeod, S.M.
  11. Comparison of the prognostic significance of the Shimada classification and N-myc copy number in neuroblastoma: A prospective study. International Journal of Oncology. 8:342-347. 1996 E. Savilo, D.G. Harnish, D. deSa, A.Willan, R. Barr.
  12. Confidence intervals for cost-effectiveness ratios: An application of Fieller's Theorem. Health Economics. 5:297-305. Addendum (1999) 8(4) 1996 A. Willan, B.J .O'Brien.
  13. Conservative Management of Mechanical Neck Disorders: A Systematic Overview and Meta-Analysis. Online J Curr Clin Trials 1996 July 30 (Doc No. 200; [34457 words, 1185 paragraphs, 10 figures, 45 tables]). Gross AR, Aker PD, Goldsmith CH, Peloso PMJ
  14. Conservative Management of Mechanical Neck Pain: Systematic Overview and Meta-Analysis. BMJ 1996;313(7068):1291-1296. Aker PD, Gross AR, Goldsmith CH, Peloso PMJ
  15. Critique of the COMMIT Study Based on the Branford Experience. Health Can Soc 1994;2(2):319-336. [Appeared in 1996]. Zanna M, Cameron R, Goldsmith CH, Poland B, Lindsay E, Walker R
  16. Design considerations in crossover trials with a single interim analysis and serial patient entry. Biometrics. 52:732-739. 1996 R.J. Cook, A. Willan.
  17. Developing a Canadian prescribing practices network. C.M.A.J., 154:1325-1331, 1996 Holbrook, A.M., MacLeod, S.M., Fisher, P., Levine, M.A.H.
  18. Diagnostic tests for temporomandibular disorders: an assessment of the methodologic quality of research reviews. Manual Therapy 1996;1(5):250-257. Gross AR, Haines T, Thomson MA, Goldsmith CH, McIntosh J
  19. Economic evaluation of pharmaceuticals: Frankenstein's monster or vampire of trials? Medical Care 1996;34:DS99-DS108. O'Brien, BJ
  20. Efficacy, Effectiveness, and Cost Analysis of Nitrate Therapy for Angina Pectoris. Final Report to the Canadian Coordinating Office of Health and Technology Assessment; Ottawa, 16 August 1996. Holbrook AM, Dolovich L, Grootendorst P, Brogan T, Kitching A, Crossley T.
  21. Ethical Considerations in the Development and Clinical Application of New Drugs. Proceedings, Ninth Broken Arrow Conference, Mont Ste. Anne , Que. (Sept. 22-23, 1995) 1996; 1-4. MacLeod, S.M.
  22. Financial Incentives to dispense low cost drugs: a case study of British Columbia Pharmacare. Final Report to Health System Policy Division, Policy and Consultation Branch; Ottawa, 31 March 1996. Grootendorst P., Goldsmith L,, Hurley J., O'Brien B., Dolovich L.
  23. Improving physician prescribing practices: Bridge over troubled waters? C.M.A.J., 154:675-677, 1996 MacLeod, S.M.
  24. Intermittent Cyclic Therapy with Etidronate Prevents Corticosteroid-Induced Bone Loss: Two Years of Follow-up. Scand J Rheumatol 1996;25(Suppl 103):91-93. Sebaldt RJ, Adachi JD, Bensen WG, Bianchi F, Cividino A, Craig GL, Cranney A, Kaminska E, Gordon M, Steele M, Goldsmith CH
  25. Managing prescription drug costs: Finding a cure. OMA Drug Report, 54:1-4, 1996 MacLeod, S.M.
  26. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Journal of the National Cancer Institute. 88:1659-1664. 1996 R. Clark, T. Whelan, M. Levine, R. Roberts, A. Willan, P. McCulloch, M. Lipa, R. Wilkinson, L. Mahoney.
  27. Reliability of the INR for monitoring the induction phase of wafarin: Comparison with the prothrombin time ratio. Journal of Laboratory and Clinical Medicine. 128:214-217. 1996 M. Johnson, L. Harrison, K. Moffat, A. Willan, J. Hirsh.
  28. Research in medical schools: rationale, priorities, roles and balance. Clin.Invest.Med., 19:204-213, 1996 MacLeod, S.M.
  29. Sertraline-associated bruxism. Canadian Journal of Clinical Pharmacology 1996;3:123-125. Pin Poor C, Watson L, Doucette D, Dolovich L.
  30. Switching the Histamine H2 Receptor antagonist famotidine to nonprescription status in Canada. An economic evaluation. PharmacoEconomics, 1996;1:61-75. Tasch, RF, Goeree, RG, Henke, CJ, O'Brien BJ.
  31. Systemic Lupus International Collaborating Clinics Conference on Assessment of Lupus Flare and Quality of Life Measures in SLE. J Rheumatol 1996;23(11):1953-1955. Gladman DD, Urowitz MB, Fortin P, Isenberg D, Goldsmith CH, Gordon C, Petri M and the Systemic Lupus International Collaborating Clinics Group
  32. The Community Intervention Trial for Smoking Cessation (COMMIT). Health Can Soc 1994;2(2):179-195. [Appeared in 1996]. Taylor SM, Goldsmith CH, Best JA
  33. The Development and Initial Validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for Systemic Lupus Erythematosus. Arthritis Rheum 1996;39(3):363-369. Gladman DD, Ginzler E, Goldsmith CH, Fortin P, Liang M, Urowitz MB, Bacon P, Bombardieri S, Hanly JG, Hay E, Isenberg D, Jones J, Kalunian K, Maddison P, Nived D, Petri M, Richter M, Sanchez-Guerrero J, Snaith M, Sturfelt G, Symmons D, Zoma A
  34. The development of a Canadian prescribing practices network. CMAJ 1996;154:1325-31. Holbrook AM, MacLeod SM, Fisher P, Levine M.
  35. The evaluation of various mathematical RBC indices and their efficacy in discriminating between thalassemic and non thalassemic microcytosis. J Hematology 1996;106:201-205. Lafferty JD, Crowther MA, Ali MA, Levine M.
  36. The Juvenile Arthritis Functional Status Index(JASI): A Validation Study. J Rheumatol 1996;23(6):1066-1079. Wright FV, Kimber JL, Law M, Goldsmith CH, Crombie V, Dent P
  37. The Future of Medical Schools. Transition and Turmoil: The Work of a Medical School Dean. Education for Health, 9:13-24, 1996 MacLeod, S.M.
  38. The value of laparoscopy among infertile women with tubal patency. J Soc Obstet Gynecol Can. 18:326-336. 1996 S. Belisle, J. Collins, E. Burrows, A. Willan.
  39. Trunk exercise combined with spinal manipulation or NSAID therapy for chronic low back pain: A randomized, observer-blinded clinical trial. J Manip Physiol Ther 1996;19(9):570-582. Bronfort G, Goldsmith CH, Nelson CF, Boline PD, Anderson AV
  40. Vitamin D and Calcium in the Prevention of Corticosteroid Induced Osteoporosis: A Three Year Follow-Up. J Rheumatol 1996;23(6):995-1000. [Reply to letter, J Rheumatol 1997;24(2):407.] Adachi JD, Bensen WG, Bianchi F, Cividino A, Pillersdorf S, Sebaldt RJ, Tugwell PSL, Gordon M, Steele M, Webber C, Goldsmith CH
  41. When do the 'dollars' make sense? Toward a conceptual framework for contingent valuation studies in health care. Medical Decision Making, 1996;16:288-299. O'Brien BJ, Gafni A.
Toronto Web Design by LinxSmart
Graphic Design by Electra